Diversification in a Concentrated Portfolio of Compounders
marcellus.in · 2026-04-16 · tier T2
Source: Memo · marcellus.in dated 2026-04-16. Auto-generated factual summary. Not investment advice. Verify before acting.
Marcellus Investment Managers' Consistent Compounders Portfolio has restructured its concentrated strategy to address macroeconomic uncertainty from AI disruption and geopolitical shifts. The portfolio exited IT services entirely and reduced large-cap exposure from 80%+ to 51% over three years, while increasing allocations to healthcare (25%), auto components, and export-led manufacturing. Top-5 holdings now span uncorrelated sectors including power transmission, pharma exports, auto OEMs, and fast fashion retail. Portfolio constituents delivered weighted average EPS growth of 10%, 14%, and 17% YoY in Q1, Q2, and Q3 FY26 respectively. The strategy emphasizes "enterprising compounders"—companies reinvesting 80-100% of cash flows to deepen competitive advantages and incubate new businesses—now representing over 70% of allocations. Marcellus identified risks including consumption growth deceleration, AI's impact on IT labor, and potential disruption of internet business models, but positioned the portfolio to benefit from export-led manufacturing emergence and healthcare sector growth.
Citations · 6
“Over the last two years, Marcellus' CCP has completely exited from exposure to IT services (TCS and HCL Tech have historically been part of the portfolio).”
p#9 · confidence 95%
“the portfolio constituents delivered weighted average EPS growth of 10%/14%/17% YoY respectively”
p#1 · confidence 95%
“reduction in allocation of large cap stocks in CCP from 80%+ till three years ago to 51% currently”
p#19 · confidence 95%
“over 70% of our allocation. Unlike traditional linear compounders, these companies aggressively reinvest 80%-100% of their cash flows”
p#18 · confidence 94%
“Current portfolio constituents delivered FY25 ROCE of 23% and a 3-year average reinvestment rate of 74%.”
p#21 · confidence 95%
“We are increasing our exposure to structurally growing sectors like healthcare (around 25% exposure currently)”
p#17 · confidence 94%
Follow this investor
Saurabh Mukherjea
Marcellus · Indian quality compounders
More from Saurabh Mukherjea
Browse all →- Saurabh MukherjeaNavigating India’s Structural Shifts
Memo
Marcellus CCP updated its quality investing playbook to focus on future flywheels and capital allocation rather than historical metrics, repositioning for India's structural shifts.
Original on marcellus.in ↗2025-12-06
- Saurabh MukherjeaEarnings Growth in India: Sliding Nifty vs Rising CCP
Memo
Marcellus' CCP portfolio delivered 14% EPS growth in FY25 vs. Nifty50's 6%, driven by moated companies with strong capital allocation.
Original on marcellus.in ↗2025-06-24
Summarized by DailySharpe AI